ゲノム全体のポリジェニックリスクスコアは,推定された球フィルタレーション傾きで,台湾の集団における慢性腎臓疾患を予測する

Gwo-Tsann Chuang^1,2, Chia-Ni Hsiung³, Tony Pan-Hou Che⁴

¹Division of Nephrology, Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.

Journal of nephrology

|September 4, 2025

まとめ

私たちは,推定されるグルメルフィルタレーション率 (eGFR) の減少のための多遺伝子リスクスコアを開発し,東アジア人群における慢性腎臓疾患 (CKD) のリスクを予測する可能性を示しました.

科学分野:

遺伝学
腎臓科
流行病学

背景:

推定グルメルフィルタレーション率 (eGFR) で測定される腎機能低下は,心血管疾患やその他の健康問題と関連しています.
これまでのEGFR変化のポリジェニックリスクスコアは,主にヨーロッパの祖先に焦点を当て,東アジアの集団での検証が欠けていました.

研究の目的:

台湾の集団におけるEGFRの傾斜に対する多遺伝子リスクスコアを開発し,検証する.
東アジア人の慢性腎臓病 (CKD) の予測力を評価する.

主な方法:

EGFRの傾きに関する全ゲノム関連研究を,糖尿病でない台湾人の26,755人に実施した.
eGFRの傾きに対するポリジェニックリスクスコアを開発しました.
58,777人の非糖尿病患者の別のコホートで,スコアとCKDの関連性を外部で検証した.

主要な成果:

SLC9A9やDEPTORのような遺伝子を含め,eGFRの傾きに関連した8つの候補ロケを特定した.
eGFRの傾きに対するポリジェニックリスクスコアを構成した.
このスコアは,検証コホートにおけるCKDを有意に予測した (P=0. 0182, OR=0. 753).

結論:

EGFR減少に対する全ゲノムポリジェニックリスクスコアは,台湾の集団で成功裏に開発され,検証されました.
このeGFR傾きポリジェニックリスクスコアは,特に東アジア人の臨床CKDリスク評価に有望である.

キーワード:

グラメルーラ濾過率の推定傾き全ゲノム関連研究多遺伝子リスクスコア

さらに関連する動画

07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.6K

04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

関連する概念動画

01:11

Genome-wide Association Studies-GWAS

14.1K

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

14.1K

01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

01:05

Single Nucleotide Polymorphisms-SNPs

15.8K

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

15.8K

01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

関連する実験動画